ICLR (ICON Public Limited Company) Stock Financials & Earnings | Market Cap Arena

ICLR (ICON Public Limited Company) Stock Financials & Earnings | Market Cap Arena

ICLRICON Public Limited Company

Mkt Cap$8B

Healthcare·Medical - Diagnostics & Research·🇮🇪 Ireland·NASDAQ

Revenue (TTM)$8.1B

Net Income (TTM)$599M

EPS (TTM)$7.39

Free Cash Flow (TTM)$996M

Gross Margin26.9%

Op. Margin12.2%

Net Margin7.4%

FCF Margin12.3%

P/S Ratio (TTM)1.0x

P/E Ratio (TTM)13.8x

YoY Rev Growth-2.5%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 11

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$2.0B	$581M	$203M
Q1 23	$2.0B	$583M	$217M
Q2 23	$2.0B	$591M	$209M
Q3 23	$2.1B	$606M	$264M
Q4 23	$2.1B	$621M	$266M
Q1 24	$2.1B	$619M	$285M
Q2 24	$2.1B	$627M	$230M
Q3 24	$2.0B	$591M	$285M
Q4 24	$2.0B	$599M	$297M
Q1 25	$2.0B	$559M	$220M
Q2 25	$2.0B	$562M	$209M
Q3 25	$2.0B	$456M	$259M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q4 22	1.1x	16.4x
Q1 23	1.1x	16.2x
Q2 23	1.0x	16.2x
Q3 23	1.0x	16.1x
Q4 23	1.0x	13.5x
Q1 24	1.0x	12.1x
Q2 24	1.0x	11.6x
Q3 24	1.0x	11.1x
Q4 24	1.0x	10.4x
Q1 25	1.0x	10.9x
Q2 25	1.0x	10.4x
Q3 25	1.0x	13.8x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$59M	-$116M
Q1 23	$176M	$149M
Q2 23	$204M	$172M
Q3 23	$342M	$312M
Q4 23	$440M	$387M
Q1 24	$327M	$300M
Q2 24	$219M	$182M
Q3 24	$403M	$359M
Q4 24	$338M	$277M
Q1 25	$268M	$239M
Q2 25	$162M	$128M
Q3 25	$409M	$352M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$57M
Q1 23	$27M
Q2 23	$32M
Q3 23	$29M
Q4 23	$53M
Q1 24	$27M
Q2 24	$36M
Q3 24	$43M
Q4 24	$61M
Q1 25	$29M
Q2 25	$35M
Q3 25	$57M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+4.1%	+1.0%
Q1 23	+4.0%	+1.8%
Q2 23	+4.4%	+3.0%
Q3 23	+5.8%	+5.4%
Q4 23	+5.3%	+2.4%
Q1 24	+5.7%	+2.4%
Q2 24	+4.9%	+4.4%
Q3 24	-1.2%	-2.6%
Q4 24	-1.2%	-3.1%
Q1 25	-4.3%	-1.3%
Q2 25	-4.8%	-4.3%
Q3 25	+0.6%	+2.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$15M	0.8%
Q1 23	$15M	0.7%
Q2 23	$17M	0.8%
Q3 23	$16M	0.8%
Q4 23	$8M	0.4%
Q1 24	$13M	0.6%
Q2 24	$15M	0.7%
Q3 24	$13M	0.6%
Q4 24	$5M	0.2%
Q1 25	$12M	0.6%
Q2 25	$15M	0.8%
Q3 25	$60M	2.9%

OpEx Breakdown

Quarter	SG&A
Q4 22	$227M
Q1 23	$200M
Q2 23	$188M
Q3 23	$185M
Q4 23	$196M
Q1 24	$177M
Q2 24	$194M
Q3 24	$205M
Q4 24	$151M
Q1 25	$198M
Q2 25	$205M
Q3 25	$197M

Revenue by Geography

Quarter	Ireland	Rest Of Europe	Rest of World	United States
Q1 23	$512M	$414M	$208M	$844M
Q2 23	$593M	$374M	$205M	$848M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$289M	$2M	$290M
Q1 23	$280M	$2M	$282M
Q2 23	$270M	$2M	$272M
Q3 23	$313M	$2M	$315M
Q4 23	$378M	$2M	$380M
Q1 24	$396M	$2M	$398M
Q2 24	$507M	$0	$507M
Q3 24	$696M	$0	$696M
Q4 24	$539M	$0	$539M
Q1 25	$527M	$0	$527M
Q2 25	$390M	$0	$390M
Q3 25	$469M	$0	$469M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	82M	-0.0%
Q1 23	83M	+0.2%
Q2 23	83M	+0.0%
Q3 23	83M	+0.4%
Q4 23	83M	+0.2%
Q1 24	83M	+0.2%
Q2 24	83M	+0.1%
Q3 24	83M	+0.1%
Q4 24	82M	-1.5%
Q1 25	82M	-0.0%
Q2 25	80M	-3.3%
Q3 25	78M	-1.8%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	$130K	10K
FY 14	$142K	11K
FY 15	$132K	12K
FY 16	$133K	13K
FY 17	$133K	13K
FY 18	$190K	14K
FY 19	$192K	15K
FY 20	$178K	16K
FY 21	$143K	38K
FY 22	$188K	41K
FY 23	$198K	41K
FY 24	$198K	42K